90 Day fiancé
NEW YORK, NY - SEPTEMBER 20: A view of signage during 2018 TLC's Give A Little Awards on September 20, 2018 at Park Hyatt in New York City. (Photo by Dia Dipasupil/Getty Images for TLC)

Reality Star Reveals ALS Diagnosis

One of the stars of "90 Day Fiancé" has revealed she has been diagnosed with ALS, also known as Lou Gehrig's disease.

Jenny Slatten of 90 Day Fiancé has revealed she has been diagnosed with ALS. 

Videos by Wide Open Country

PEOPLE reported the news. The 68-year-old and her husband, Sumit Singh, shared the news as they prepare to appear on the third season of the reality show's spinoff, 90 Day: The Last Resort, next month. 

It Was A Fan That Helped the "90 Day Fiancé" Star

The 90 Day Fiancé couple began to notice symptoms of ALS, or amyotrophic lateral sclerosis, back in December 2024. 

According to the National Institute of Neurological Disorders and Stroke, the neurological disorder, which is also known as Lou Gehrig's disease, affects the cells that control muscle movement and breathing. As these cells degenerate and die, they stop sending messages to the muscles, causing them to weaken and atrophy. The brain has trouble controlling the body, making simple functions such as walking, chewing, and breathing more difficult. There is no cure. 

Singh noticed that Slatten had trouble drinking water and swallowing pills. Eventually, her speech slowed, and she refused to speak. 

Slatten said, "That's when we knew something was wrong."

Fans became concerned for Slatten after an appearance at a 90 Day Fiancé party in New York City in December 2025. A fan suggested she may have ALS. 

"And then I find out that these symptoms she was having — this is what it looks like," said Singh. 

Slatten then remembered that the disease claimed her father. When she returned to India, she was officially diagnosed with ALS. 

"We cried and held each other," said Slatten. 

What's Next for Jenny Slatten?

Doctors informed Jenny that her ALS progression is "slow." She and Singh are now seeking treatments to manage her symptoms. 

Slatten is considering genetic testing, which could qualify her for medication to slow disease progression. She is also learning about ALS and treatments through online communities. 

"Right now we're just looking and searching," said Slatten. She hopes that "maybe somebody will come forward with something" that could help.

Despite her diagnosis, Slatten and Singh continue to find strength and hope in each other. 

"I don't want to be treated any different," says Slatten. "Let's just live our life as we have been while we can."